Urine Extracellular Vesicles Size Subsets as Lupus Nephritis Biomarkers

Area of Science:

• Nephrology
• Immunology
• Biomarker Discovery

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease.
• Lupus nephritis (LN) is a common and serious complication of SLE, causing kidney damage.
• Current diagnostic methods like renal biopsy are invasive and unsuitable for routine monitoring.

Purpose of the Study:

• To investigate urinary extracellular vesicles (uEVs) as potential non-invasive biomarkers for lupus nephritis (LN).
• To evaluate the diagnostic utility of uEV concentration and size distribution in distinguishing LN patients.

Main Methods:

• Development of a flow cytometry approach to analyze uEVs in urine.
• Comparison of uEV concentration and size profiles between LN patients and SLE patients without kidney involvement.

Main Results:

• LN patients exhibited significantly higher total uEV concentrations than SLE patients without kidney disease.
• Microvesicles within the 0.3–0.5 μm size range were most effective in differentiating LN.
• uEV analysis showed potential for distinguishing LN patients.

Conclusions:

• Urinary extracellular vesicle concentration and size distribution analysis represent a promising, non-invasive tool for LN diagnosis and monitoring.
• Further validation in larger studies is warranted to confirm the clinical utility of uEVs for LN.